Setyani Wahyuning, Murwanti Retno, Sulaiman Teuku Nanda Saifullah, Hertiani Triana
Pharmaceutical Sciences Doctoral Study Program, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia.
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Sanata Dharma, Yogyakarta 55282, Indonesia.
Plants (Basel). 2023 Jun 26;12(13):2455. doi: 10.3390/plants12132455.
This study optimized ultrasound-assisted extraction conditions to maximize the extraction yield, total flavonoid content (TFC), total phenolic content (TPC), and DPP IV enzyme inhibitory activity from . The four UAE factors, solvent ratio (A), solvent-solid ratio (B), extraction temperature (C), and extraction time (D), were optimized using response surface methodology (RSM). A Box-Behnken design was used for the experimental design. The optimal conditions were found to be a 50% solvent ratio, a 30% solvent-solid ratio, 35 °C extraction temperature, and 45 min extraction time. The experimental value of extraction yield (), TFC (), TPC (), and DPP IV enzyme inhibitory activity () (87.99% , 56.63 mg QE/g extract, 97.26 mg GAE/g extract, and 93.32% inhibition, respectively) agreed with those predicted by RSM models (88.10% , 56.61 mg QE/g extract, 97.16 mg GAE/g extract, and93.38% inhibition, respectively), thus demonstrating the appropriateness of the model used and the ability of the RSM to optimize the extraction conditions. Excellent DPP IV enzyme inhibitory activity was exhibited by compared with the standard, sitagliptin. While the modeled equation fits the data, the t-test is not significant, suggesting that the experimental values agree with those predicted by the RSM-BBD.
本研究优化了超声辅助提取条件,以最大化从……中的提取产率、总黄酮含量(TFC)、总酚含量(TPC)和二肽基肽酶IV(DPP IV)酶抑制活性。使用响应面法(RSM)对四个超声辅助提取因素,即溶剂比例(A)、溶剂与固体比例(B)、提取温度(C)和提取时间(D)进行了优化。采用Box-Behnken设计进行实验设计。发现最佳条件为50%的溶剂比例、30%的溶剂与固体比例、35℃的提取温度和45分钟的提取时间。提取产率()、TFC()、TPC()和DPP IV酶抑制活性()的实验值(分别为87.99%、56.63 mg QE/g提取物、97.26 mg GAE/g提取物和93.32%抑制率)与RSM模型预测的值(分别为88.10%、56.61 mg QE/g提取物、97.16 mg GAE/g提取物和93.38%抑制率)相符,从而证明了所用模型的适用性以及RSM优化提取条件的能力。与标准药物西格列汀相比,……表现出优异的DPP IV酶抑制活性。虽然模型方程与数据拟合,但t检验不显著,表明实验值与RSM-BBD预测的值相符。